Gagnidze, K., Rayon-Estrada, V., Harroch, S., Bulloch, K. & Papavasiliou, F. N. A new chapter in genetic medicine: RNA editing and its role in disease pathogenesis. Trends Mol. Med. 24, 294–303 (2018).
Gold, A., Levanon, E. Y. & Eisenberg, E. The new RNA-editing era—ethical considerations. Trends Genet. 37, 685–687 (2021).
Casati, B., Pinamonti, V., Pecori, R., Lindner, J. M. & Papavasiliou, F. N. Neoepitope formation through the generation of RNA-derived ‘editopes’. Preprint at bioRxiv https://doi.org/10.1101/2023.03.16.532918 (2023).
Booth, B. J. et al. RNA editing: expanding the potential of RNA therapeutics. Mol. Ther. 31, 1533–1549 (2023).
Diaz Quiroz, J. F., Siskel, L. D. & Rosenthal, J. J. C. Site-directed A → I RNA editing as a therapeutic tool: moving beyond genetic mutations. RNA 29, 498–505 (2023).
Dadush, A. et al. DNA and RNA base editors can correct the majority of pathogenic single nucleotide variants. NPJ Genom. Med. 9, 16 (2024).
Chen, L.-L. et al. Voices: challenges and opportunities in RNA biology. Cell Chem. Biol. 31, 10–13 (2024).
Khosravi, H. M. & Jantsch, M. F. Site-directed RNA editing: recent advances and open challenges. RNA Biol. 18, 41–50 (2021).
Pfeiffer, L. S. & Stafforst, T. Precision RNA base editing with engineered and endogenous effectors. Nat. Biotechnol. 41, 1526–1542 (2023).
Stafforst, T. & Schneider, M. F. An RNA-deaminase conjugate selectively repairs point mutations. Angew. Chem. Int. Ed. 51, 11166–11169 (2012).
Montiel-Gonzalez, M. F., Vallecillo-Viejo, I., Yudowski, G. A. & Rosenthal, J. J. C. Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. Proc. Natl Acad. Sci. USA 110, 18285–18290 (2013).
Cox, D. B. T. et al. RNA editing with CRISPR–Cas13. Science 358, 1019–1027 (2017).
Sinnamon, J. R. et al. Site-directed RNA repair of endogenous Mecp2 RNA in neurons. Proc. Natl Acad. Sci. USA 114, E9395–E9402 (2017).
Wettengel, J., Reautschnig, P., Geisler, S., Kahle, P. J. & Stafforst, T. Harnessing human ADAR2 for RNA repair—recoding a PINK1 mutation rescues mitophagy. Nucleic Acids Res. 45, 2797–2808 (2017).
Fukuda, M. et al. Construction of a guide-RNA for site-directed RNA mutagenesis utilising intracellular A-to-I RNA editing. Sci. Rep. 7, 41478 (2017).
Vogel, P. et al. Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs. Nat. Methods 15, 535–538 (2018).
Katrekar, D. et al. In vivo RNA editing of point mutations via RNA-guided adenosine deaminases. Nat. Methods 16, 239–242 (2019).
Merkle, T. et al. Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides. Nat. Biotechnol. 37, 133–138 (2019).
Reautschnig, P. et al. CLUSTER guide RNAs enable precise and efficient RNA editing with endogenous ADAR enzymes in vivo. Nat. Biotechnol. 40, 759–768 (2022).
Katrekar, D. et al. Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs. Nat. Biotechnol. 40, 938–945 (2022).
Yi, Z. et al. Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo. Nat. Biotechnol. 40, 946–955 (2022).
Monian, P. et al. Endogenous ADAR-mediated RNA editing in non-human primates using stereopure chemically modified oligonucleotides. Nat. Biotechnol. 40, 1093–1102 (2022).
Wong, S. K., Sato, S. & Lazinski, D. W. Substrate recognition by ADAR1 and ADAR2. RNA 7, 846–858 (2001).
Lehmann, K. A. & Bass, B. L. The importance of internal loops within RNA substrates of ADAR1. J. Mol. Biol. 291, 1–13 (1999).
Tian, N. et al. A structural determinant required for RNA editing. Nucleic Acids Res. 39, 5669–5681 (2011).
Eggington, J. M., Greene, T. & Bass, B. L. Predicting sites of ADAR editing in double-stranded RNA. Nat. Commun. 2, 319 (2011).
Ramaswami, G. et al. Genetic mapping uncovers cis-regulatory landscape of RNA editing. Nat. Commun. 6, 8194 (2015).
Song, Y. et al. irCLASH reveals RNA substrates recognized by human ADARs. Nat. Struct. Mol. Biol. 27, 351–362 (2020).
Zhang, H. et al. Human A-to-I RNA editing SNP loci are enriched in GWAS signals for autoimmune diseases and under balancing selection. Genome Biol. 21, 288 (2020).
Liu, X. et al. Learning cis-regulatory principles of ADAR-based RNA editing from CRISPR-mediated mutagenesis. Nat. Commun. 12, 2165 (2021).
Uzonyi, A. et al. Deciphering the principles of the RNA editing code via large-scale systematic probing. Mol. Cell 81, 2374–2387.e3 (2021).
Zambrano-Mila, M. S. et al. Dissecting the basis for differential substrate specificity of ADAR1 and ADAR2. Nat. Commun. 14, 8212 (2023).
Jacobsen, C. S. et al. Library screening reveals sequence motifs that enable ADAR2 editing at recalcitrant sites. ACS Chem. Biol. 18, 2188–2199 (2023).
Diaz Quiroz, J. F. et al. Development of a selection assay for small guide RNAs that drive efficient site-directed RNA editing. Nucleic Acids Res. 51, e41 (2023).
Levanon, E. Y. et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat. Biotechnol. 22, 1001–1005 (2004).
Bazak, L. et al. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes. Genome Res. 24, 365–376 (2014).
Tan, M. H. et al. Dynamic landscape and regulation of RNA editing in mammals. Nature 550, 249–254 (2017).
Kleinberger, Y. & Eisenberg, E. Large-scale analysis of structural, sequence and thermodynamic characteristics of A-to-I RNA editing sites in human Alu repeats. BMC Genomics 11, 453 (2010).
Bazak, L., Levanon, E. Y. & Eisenberg, E. Genome-wide analysis of Alu editability. Nucleic Acids Res. 42, 6876–6884 (2014).
Yamamoto, R., Liu, Z., Choudhury, M. & Xiao, X. dsRID: in silico identification of dsRNA regions using long-read RNA-seq data. Bioinformatics 39, btad649 (2023).
Matthews, M. M. et al. Structures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivity. Nat. Struct. Mol. Biol. 23, 426–433 (2016).
Roberts, T. C., Langer, R. & Wood, M. J. A. Advances in oligonucleotide drug delivery. Nat. Rev. Drug Discov. 19, 673–694 (2020).
Strnad, P., McElvaney, N. G. & Lomas, D. A. Alpha1-Antitrypsin Deficiency. N. Engl. J. Med. 382, 1443–1455 (2020).
Doherty, E. E. et al. ADAR activation by inducing a syn conformation at guanosine adjacent to an editing site. Nucleic Acids Res. 50, 10857–10868 (2022).
Pecori, R. & Papavasiliou, N. F. It takes two (and some distance) to tango: how ADARs join to edit RNA. Nat. Struct. Mol. Biol. 27, 308–310 (2020).
Yu, G., Wang, L. G. & He, Q. Y. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382–2383 (2015).
Ramaswami, G. & Li, J. B. RADAR: a rigorously annotated database of A-to-I RNA editing. Nucleic Acids Res. 42, D109–D113 (2014).
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
Rehmsmeier, M., Steffen, P., Hochsmann, M. & Giegerich, R. Fast and effective prediction of microRNA/target duplexes. RNA 10, 1507–1517 (2004).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Litke, J. L. & Jaffrey, S. R. Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts. Nat. Biotechnol. 37, 667–675 (2019).
Charni-Natan, M. & Goldstein, I. Protocol for primary mouse hepatocyte isolation. STAR Protoc. 1, 100086 (2020).
